Abstract
dl-Praeruptorin A (Pd-Ia) is the major active constituent of the traditional Chinese medicine Peucedanum praeruptorum Dunn. Recently it has been identified as a novel agent in the treatment and prevention of cardiovascular diseases. Accordingly, we investigated the metabolism of Pd-Ia in rat liver microsomes. The involvement of cytochrome P450 (CYP) and CYP isoforms were identified using a CYP-specific inhibitor (SKF-525A), CYP-selective inhibitors (α-naphthoflavone, metyrapone, fluvastatin, quinidine, disulfiram, ketoconazole and ticlopidine) and CYP-selective inducers (phenobarbital, dexamethasone and β-naphthoflavone). Residual concentrations of the substrate and metabolites were determined by HPLC, and further identified by their mass spectra and chromatographic behavior. These experiments showed that CYP450 is involved in Pd-Ia metabolism, and that the major CYP isoform responsible is CYP3A1/2, which acts in a concentration-dependent manner. Four Pd-Ia metabolites (M1, M2, M3, and M4) were detected after incubation with rat liver microsomes. Hydroxylation was the primary metabolic pathway of Pd-Ia, and possible chemical structures of the metabolites were identified. Further research is now needed to link the metabolism of Pd-Ia to its drug-drug interactions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Born, S. L., Caudill, D., Fliter, K. L., and Purdon, M. P., Identification of the cytochromes P450 that catalyze coumarin 3,4-epoxidation and 3-hydroxylation. Drug Metab. Dispos., 30, 483–487 (2002).
Brady, J. F., Xiao, F., Wang, M. H., Li, Y., Ning, S. M., Gapac, J. M., and Yang, C. S., Effects of disulfiram on hepatic P450 IIE1, other microsomal enzymes and hepatotoxicity in rats. Toxicol. Appl. Pharmacol., 108, 366–373 (1991).
Chang, H., Chu, X. Y., Zou, J., and Chang, T. H., Effects of peucedanum praeruptorum dunn, a traditional Chinese medicine on acute myocardial infarction in open chest anesthetized cats. J. China Med. Univ., 29, 84–87 (2000).
Chang, T. H., Liu, X. Y., Zhang, X. H., and Wang, H. L., Effects of dl-praeruptorin A on interleukin-6 level and Fas, bax, bcl-2 protein expression in ischemia-reperfusion myocardium. Acta Pharmacol. Sin., 23, 769–774 (2002).
Chung, H. J., Choi, Y. H., Kim, S. H., and Lee, M. G., Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous ipriflavone in rats. J. Pharm. Pharmacol., 58, 449–457 (2006).
Chung, Y. B., Bae, W. T., and Han, K., Metabolism of an anionic fluorescent dye, 1-anilino-8-naphthalene sulfonate (ANS) by rat liver microsomes. Arch. Pharm. Res., 21, 677–682 (1998).
Dresser, G. K., Spence, J. D., and Bailey, D. G., Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clin. Pharmacokinet., 38, 41–57 (2000).
Gibbs, M. A., Kunze, K. L., Howald, W. N., and Thummel, K. E., Effect of inhibitor depletion on inhibitory potency: tight binding inhibition of CYP3A by clotrimazole. Drug Metab. Dispos., 27, 596–599 (1999).
Goshman, L., Fish, J., and Roller, K., Ritonavir, Clinically significant cytochrome P450 drug interactions. J. Pharm. Soc. Wis., 5, 23–28 (1999).
Hsu, A., Granneman, G. R., and Bertz, R. J., Ritonavir. Clinical pharmacokinetics and interactions with other anti-HIV agents. Clin. Pharmacokinet., 35, 275–291 (1998).
Huong, D. T., Choi, H. C., Rho, T. C., Lee, H. S., Lee, M. K., and Kim, Y. H., Inhibitory activity of monoamine oxidase by coumarins from Peucedanum japonicum. Arch. Pharm. Res., 22, 324–326 (1999).
Kamataki, T. and Kitagawa, H., Effects of lyophilization and storage of rat liver microsomes on activity of aniline hydroxylase, contents of cytochrome b5 and cytochrome p-450 and aniline-induced p-450 difference spectrum. Jpn. J. Pharmacol., 24, 195–203 (1974).
Kozawa, T., Sakai, K., Uchida, M., Okuyama, T., and Shibata, S., Calcium antagonistic action of a coumarin isolated from “Qian-Hu”, a Chinese traditional medicine. J. Pharm. Pharmacol., 33, 317–320 (1981).
Krippendorff, B. F., Lienau, P., Reichel, A., and Huisinga, W., Optimizing classification of drug-drug interaction potential for CYP450 isoenzyme inhibition assays in early drug discovery. J. Biomol. Screen, 12, 92–99 (2007).
Krishnan, S. and Moncrief, S., An evaluation of the cytochrome p450 inhibition potential of lisdexamfetamine in human liver microsomes. Drug Metab. Dispos., 35, 180–184 (2007).
Lakshmi, V. M., Zenser, T. V., and Davis, B. B., Rat liver cytochrome P450 metabolism of N-acetylbenzidine and N, N′-diacetylbenzidine. Drug Metab. Dispos., 25, 481–488 (1997).
Lewis, D. F., Ito, Y., and Lake, B. G., Metabolism of coumarin by human P450s: a molecular modelling study. Toxicol. In Vitro, 20, 256–264 (2006).
Lin, N., Chang, T. H., Xu, H. T., Du, Z. J., and Wang, X. F., Praeruptorin A upregulates expression of nestin in experimental autoimmune myocarditis of rats. Pharmacology and Clinics of Chinese Materia Medica, 23, 21–23 (2007).
Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265–275 (1951).
Lu, M., Nicoletti, M., Battinelli, L., and Mazzanti, G., Isolation of praeruptorins A and B from Peucedanum praeruptorum Dunn. and their general pharmacological evaluation in comparison with extracts of the drug. Farmaco, 56, 417–420 (2001).
Meyer, R. P., Gehlhaus, M., Schwab, R., Bürck, C., Knoth, R., and Hagemeyer, C. E., Concordant up-regulation of cytochrome P450 Cyp3a11, testosterone oxidation and androgen receptor expression in mouse brain after xenobiotic treatment. J. Neurochem., 109, 670–681 (2009).
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., and Guengerich, F. P., Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther., 270, 414–423 (1994).
Sun, S., Kong, L. Y., Zhang, H. Q., and He, S. A., Total asymmetric synthesis of 3′ R, 4′ R —disubstituted angular dihydropyranocoumarins. J. China Pharm. Univ., 36, 205–209 (2005).
Testa, B. and Jenner, P., Inhibitors of cytochrome P-450s and their mechanism of action. Drug Metab. Rev., 12, 1–117 (1981).
Tolonen, A., Turpeinen, M., and Pelkonen, O., Liquid chromatography-mass spectrometry in vitro drug metabolite screening. Drug Discov. Today, 14, 120–133 (2009).
Transon, C., Leemann, T., and Dayer, P., In vivo comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors. Eur. J. Clin. Pharmacol., 50, 209–215 (1996).
Tu, X., Miao, L., Kang, Y., Xia, H., Tu, J. W., Wang, Q., Tu, Q., Wang, J. M., and Hao, H., Effects of dI-praeruptorin A on cultured neonatal rat ventricular cardiomyocytes with hypertrophy induced by endothelin-1. Methods Find Exp. Clin. Pharmacol., 31, 231–236 (2009).
Walsky, R. L. and Obach, R. S., A comparison of 2-phenyl-2-(1-piperidinyl)propane (ppp), 1,1′,1″-phosphinothioylidynetrisaziridine (thio TEPA), clopidogrel, and ticlopidine as selective inactivators of human cytochrome P450 2B6. Drug Metab. Dispos., 35, 2053–2059 (2007).
Wright, M. C. and Paine, A. J., Induction of the cytochrome P450 3A subfamily in rat liver correlates with the binding of inducers to a microsomal protein. Biochem. Biophys. Res. Commun., 201, 973–979 (1994).
Xia, Z. L., Ying, J. Y., Sheng, R., Zeng, S., Hu, Y. Z., and Yao, T. W., In vitro metabolism of BYZX in human liver microsomes and the structural elucidation of metabolite by liquid chromatography-mass spectrometry method. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 857, 266–274 (2007).
Zhang, Z., Liu, Y. Y., Su, M. Q., Liang, X. F., Wang, W. F., and Zhu, X., Pharmacokinetics, tissue distribution and excretion study of dl-praeruptorin A of Peucedanum praeruptorum in rats by liquid chromatography tandem mass spectrometry. Phytomedicine, 18, 527–532 (2011).
Zhu, G. Y., Chen, G. Y., Li, Q. Y., Shen, X. L., and Fang, H. X., HPLC/ MS/ MS Method for chemical profiling of radix peucedani (Baihua Quanhu). Chin. J. Nat. Med., 9, 304–308 (2004).
Zhuo, X., Gu, J., Zhang, Q. Y., Spink, D. C., Kaminsky, L. S., and Ding, X., Biotransformation of coumarin by rodent and human cytochromes P-450: metabolic basis of tissueselective toxicity in olfactory mucosa of rats and mice. J. Pharmacol. Exp. Ther., 288, 463–471 (1999).
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this work.
Rights and permissions
About this article
Cite this article
Ruan, H., Zhang, Z., Liang, Xf. et al. Metabolism of dl-praeruptorin a in rat liver microsomes using HPLC-electrospray ionization tandem mass spectrometry. Arch. Pharm. Res. 34, 1311–1321 (2011). https://doi.org/10.1007/s12272-011-0811-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-011-0811-y